Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient
- PMID: 4097745
- PMCID: PMC1712861
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient
Abstract
Two IgEL and one IgGK producing cell lines have been established in vitro from peripheral blood and bone marrow of an E myeloma patient. Morphologic and immunologic studies indicate that cells of the IgE producing lines are derived from the same clone of myeloma cells which grew in vivo. They have remained essentially unaltered with a stable near-diploid karyotype and continuous production of intact IgE molecules during 18 months in culture. The IgGK producing line has all the characteristics ascribed to permanent lymphoblastoid lines and is considered to be of non-malignant lymphoid origin. The process of establishment is described and it is suggested that lymphoblastoid cells have a selective advantage over myeloma cells. Permanent myeloma cell lines can therefore probably be obtained only if cells capable of forming established lymphoblastoid lines are very few or absent in the original biopsy. The establishment of a permanent cell line continuously producing intact molecules of IgE should permit further studies on the biological role of this class of immunoglobulins.
Similar articles
-
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines.J Immunol. 1973 Aug;111(2):448-56. J Immunol. 1973. PMID: 4123978 No abstract available.
-
Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.Clin Exp Immunol. 1984 Sep;57(3):743-51. Clin Exp Immunol. 1984. PMID: 6380841 Free PMC article.
-
[Immunofluorescence optical studies for the differentiation of monoclonal and polyclonal increases in immunoglobulin producing bone marrow cells].Schweiz Med Wochenschr. 1974 Sep 28;104(39):1395-6. Schweiz Med Wochenschr. 1974. PMID: 4214489 German. No abstract available.
-
Use of tracer techniques in studies on immunoglobulin-producing cells.J Histochem Cytochem. 1973 Mar;21(3):209-17. doi: 10.1177/21.3.209. J Histochem Cytochem. 1973. PMID: 4121416 Review. No abstract available.
-
[An autopsy case of IgE myeloma].Rinsho Ketsueki. 1989 May;30(5):686-90. Rinsho Ketsueki. 1989. PMID: 2507800 Review. Japanese.
Cited by
-
Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.Immunology. 1989 Apr;66(4):505-11. Immunology. 1989. PMID: 2523859 Free PMC article.
-
Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction.J Clin Pathol. 1992 May;45(5):420-3. doi: 10.1136/jcp.45.5.420. J Clin Pathol. 1992. PMID: 1597520 Free PMC article.
-
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.Clin Exp Immunol. 2006 Jun;144(3):528-33. doi: 10.1111/j.1365-2249.2006.03078.x. Clin Exp Immunol. 2006. PMID: 16734623 Free PMC article.
-
The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.J Biol Chem. 2004 Oct 1;279(40):42258-69. doi: 10.1074/jbc.M407496200. Epub 2004 Jul 13. J Biol Chem. 2004. PMID: 15252056 Free PMC article.
-
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.Anticancer Drugs. 2016 Sep;27(8):756-65. doi: 10.1097/CAD.0000000000000389. Anticancer Drugs. 2016. PMID: 27276402 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials